Skip to main content

HAIRY LEUKOPLAKIA

Tracking # 20-1057164

$99999.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Computer-Based Training

Course overview

HAIRY LEUKOPLAKIA (HL) WAS FIRST DESCRIBED IN 1984 AND IS A DISEASE OF THE MUCOSA. IT IS ASSOCIATED WITH EPSTEIN-BARR VIRUS (EBV), ALSO KNOWN AS HUMAN HERPESVIRUS 4. IT OCCURS MOST COMMONLY IN PEOPLE INFECTED WITH HIV, ALTHOUGH IT CAN ALSO BE SEEN IN PEOPLE WHO DO NOT HAVE HIV. SUCH PATIENTS ARE USUALLY THOSE WHO HAVE HAD AN ORGAN OR BONE MARROW TRANSPLANT OR SOME IMMUNOCOMPROMISED DISEASE OR HEMATOLOGICAL MALIGNANCY. THIS ACTIVITY DESCRIBES THE EVALUATION AND MANAGEMENT OF HAIRY LEUKOPLAKIA AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN IMPROVING CARE FOR PATIENTS WITH THIS CONDITION.

Subject areas

This course counts toward the state boards and subject areas below.

Bahamas Medical Council

Specialty Medical Practitioner

1h General Medicine

Louisiana State Board of Medical Examiners - Physicians & Surgeons

Physician & Surgeon

1h Category I CME

Mississippi State Board of Medical Licensure

Medical Doctor

1h AMA Category I

Physician Assistant

1h AMA Category I

State Medical Board of Ohio

Doctor of Medicine

1h AMA Category I